Doccla is a technology company.
Doccla is a leading provider of virtual care solutions in Europe, offering services such as virtual wards, remote patient monitoring, and proactive care to improve healthcare delivery and patient outcomes.
Doccla has raised $66.0M across 3 funding rounds.
Doccla has raised $66.0M in total across 3 funding rounds.
# Doccla: Virtual Wards and Remote Patient Monitoring
Doccla is a healthcare technology company that enables hospitals and health systems to deliver care outside traditional hospital settings through virtual wards and remote patient monitoring.[1][3] Founded in 2019 and based in London, the company provides an end-to-end platform that combines medical-grade devices, logistics management, patient onboarding, electronic health record (EHR) integration, and clinical support to shift patient care from hospitals to homes.[2][3]
The company solves a critical problem in modern healthcare: hospital capacity constraints and the rising costs of inpatient care. By enabling early discharge, acute recovery at home, and long-term condition management through remote monitoring, Doccla helps health systems reduce non-elective hospital admissions while improving patient outcomes.[2] The company operates across 11 European countries and partners with over 60% of NHS Integrated Care Boards, monitoring millions of patient days annually.[2][3]
Doccla was founded in 2019 during a period of growing recognition that remote care delivery could transform healthcare efficiency.[1] The company emerged from the insight that hospitals needed a comprehensive, integrated solution—not just monitoring devices or software alone, but a full-stack offering that handled logistics, clinical workflows, and data integration simultaneously.[2]
The company's early traction came through partnerships with the NHS and European health providers, positioning it as a trusted partner in public healthcare systems rather than pursuing a direct-to-consumer model.[2] This institutional focus established credibility and provided a stable foundation for scaling across multiple European markets.
Doccla operates at the intersection of two powerful healthcare trends: the shift toward value-based care and the digital transformation of health systems. Hospitals worldwide face mounting pressure to reduce costs while improving outcomes—a tension that remote patient monitoring directly addresses by preventing costly hospital readmissions and enabling earlier discharge.
The timing is particularly favorable. Post-pandemic, health systems have accelerated digital adoption and demonstrated willingness to invest in virtual care infrastructure. Simultaneously, regulatory frameworks in Europe (including the NHS's emphasis on virtual wards) have created policy tailwinds for companies like Doccla.[2] The company's focus on public healthcare systems rather than fragmented private markets gives it stability and scale that many digital health startups lack.
Doccla's emphasis on interoperability and clinical integration—rather than attempting to replace existing systems—positions it as an enabler of the broader healthcare IT ecosystem rather than a disruptor. This approach has proven more sustainable in regulated healthcare markets where change management and clinical governance are paramount.
Doccla is well-positioned to capture significant value as European health systems continue prioritizing virtual care and hospital capacity management. The company's institutional relationships with NHS ICBs and European providers provide a durable competitive moat and recurring revenue base. Recent investment activity, including backing from Bertelsmann Investments, signals confidence in the company's growth trajectory.[4]
The key question ahead is whether Doccla can expand beyond Europe and replicate its NHS-centric model in other regulated markets (particularly the United States), where fragmented healthcare systems and different reimbursement models present both opportunities and challenges. Success will depend on maintaining its clinical credibility while scaling operations across diverse healthcare environments. As health systems face persistent capacity pressures and rising labor costs, the demand for proven virtual care platforms will likely intensify—positioning Doccla as a critical infrastructure provider in the evolving healthcare landscape.
Doccla has raised $66.0M in total across 3 funding rounds.
Doccla's investors include Amino Collective, Cherry Ventures, FasterCapital, General Catalyst, Lakestar, Rethink Impact, Town Hall Ventures, Christian Reber, Florian Otto, Lucas Cranach, Germin8 Ventures, Giant Ventures.
Doccla has raised $66.0M across 3 funding rounds. Most recently, it raised $46.0M Series B in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2024 | $46.0M Series B | Amino Collective, Cherry Ventures, FasterCapital, General Catalyst, Lakestar, Rethink Impact, Town Hall Ventures, Christian Reber, Florian Otto, Lucas Cranach | |
| Sep 1, 2022 | $17.0M Series A | General Catalyst, Germin8 Ventures, Giant Ventures, Rethink Impact, SOSV, Town Hall Ventures, Trucks Venture Capital | |
| Sep 1, 2021 | $3.0M Seed | Germin8 Ventures, Giant Ventures, SOSV, Trucks Venture Capital |